Protagonist Therapeutics

PTGX

Börsenwert 8,89 Mrd. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
326	326 Prestige Wealth Management Group Flemington, New Jersey	1.226 $	+731 $	+7	+233 %
327	327 Gilpin Wealth Management Denver, Colorado	1.104 $	–	–	–
328	328 JFS Wealth Advisors Hermitage, Pennsylvania	1.104 $	+940 $	+9	Neu
329	329 Rossby Financial Melbourne, Florida	1.103 $	–	–	–
330	APFP 330 Action Point Financial Planning Grand Rapids, Michigan	1.103 $	+1.045 $	+10	Neu
331	331 Hughes Financial Services Herndon, Virginia	981 $	+209 $	+2	+33 %
332	NWMP 332 Noble Wealth Management PBC Greenwood Village, Colorado	981 $	+836 $	+8	Neu
333	333 Trust Company Manhattan, Kansas	858 $	–	–	–
334	334 Ares Financial Consulting Calabasas, California	735 $	+627 $	+6	Neu
335	335 Rialto Wealth Management Syracuse, New York	613 $	+522 $	+5	Neu
336	336 DecisionPoint Financial Mesa, Arizona	501 $	–	–	–
337	337 Kilter Group Rhinebeck, New York	491 $	–	–	–
338	338 SJS Investment Consulting Sylvania, Ohio	491 $	+418 $	+4	Neu
339	339 Davis Capital Management Jacksonville, Florida	368 $	+313 $	+3	Neu
340	340 Stone House Investment Management Tunkhannock, Pennsylvania	368 $	+313 $	+3	Neu
341	341 Abound Wealth Management Franklin, Tennessee	246 $	–	–	–
342	342 Walleye Capital New York	123 $	+104 $	+1	Neu
343	343 Citadel Advisors Miami, Florida	–	-162 Mio. $	-1.551.900	Geschlossen
344	344 Nationale-Nederlanden Powszechne Towarzystwo Emerytalne Warszawa, Poland	–	-60,3 Mio. $	-571.825	Geschlossen
345	345 Rubric Capital Management (New York) New York	–	-45,1 Mio. $	-427.998	Geschlossen
346	346 Vestal Point Capital New York	–	-34,4 Mio. $	-326.159	Geschlossen
347	347 Adage Capital Partners Boston, Massachusetts	–	-29,8 Mio. $	-282.436	Geschlossen
348	348 Integral Health Asset Management New York	–	-5,27 Mio. $	-50.000	Geschlossen
349	349 Royce & Associates New York	–	-1,51 Mio. $	-14.349	Geschlossen
350	350 Hussman Strategic Advisors Ellicott City, Maryland	–	-1,11 Mio. $	-10.500	Geschlossen

Protagonist Therapeutics PTGX Börsenwert 8,89 Mrd. $

Protagonist Therapeutics

PTGX

Börsenwert 8,89 Mrd. $